{
}
Credit Suisse faced severe repercussions for its handling of U.S. black money accounts, culminating in a $2.8 billion settlement and a criminal conviction. Despite efforts like "Operation Valentina" to disclose U.S. accounts, the bank failed to address numerous violations, leading to further financial penalties after its acquisition by UBS. Key executives, including Urs Rohner and Romeo Cerutti, are implicated in the systematic failures that allowed these issues to persist.
UBS analyst Dan Leonard has lowered the price target for Bruker (BRKR) to $45 from $57, marking a 21.05% decrease, while maintaining a 'Neutral' rating. The average price target from 13 analysts stands at $54.90, suggesting a potential upside of 33.49% from the current price of $41.13. Additionally, GuruFocus estimates the fair value of Bruker at $88.47, indicating a possible upside of 115.12%.
UBS analyst Jonathan Yong has lowered the price target for eHealth (EHTH) from $9.50 to $7.00, maintaining a "Neutral" rating, reflecting a 26.32% decrease. Analysts forecast an average target price of $10.63, suggesting a potential upside of 94.24% from the current price of $5.47, while the consensus recommendation remains a "Hold" with an average rating of 2.8.
UBS analyst Lu Li has maintained a "Buy" rating for Veracyte (VCYT) while lowering the stock's price target from $49.00 to $42.00, reflecting a 14.29% decrease. Despite this adjustment, the average target price from 11 analysts is $43.73, suggesting a potential upside of 40.47% from the current price of $31.13. Additionally, the consensus recommendation from 13 brokerage firms indicates an "Outperform" status with an average rating of 1.9.
UBS has maintained a "Neutral" rating on Angi (ANGI) while lowering its price target from $24.00 to $20.00, reflecting a 16.67% decrease in expected stock valuation. Analysts project an average target price of $26.94, indicating a potential upside of 76.64% from the current price of $15.25, with a consensus recommendation of "Hold." GuruFocus estimates a fair value of $17.55 for Angi, suggesting a 15.08% upside.
UBS has lowered its price target for Amplitude (AMPL) from $13.00 to $11.00, a decrease of 15.38%, while maintaining a "Neutral" rating. Analysts project an average target price of $13.10, indicating a potential upside of 21.52% from the current price of $10.78. GuruFocus estimates a fair value of $13.70, suggesting a 27.09% upside.
Barclays has maintained an "Equal-Weight" rating for B&G Foods (BGS) while significantly lowering its price target from $7.00 to $5.00, reflecting a 28.57% decrease. Analysts project an average target price of $7.00, indicating a potential upside of 57.84% from the current price of $4.44. GuruFocus estimates a fair value of $9.02 for the stock, suggesting a 103.38% upside.
On May 8, 2025, Barclays analyst Raimo Lenschow maintained an "Equal-Weight" rating for Dayforce (DAY), indicating the stock is expected to perform in line with market benchmarks. The price target was adjusted down from USD 61.00 to USD 60.00, reflecting a cautious outlook on the company's near-term financial performance.
Barclays has lowered its price target for CEVA from $40.00 to $30.00 while maintaining an "Overweight" rating, indicating a positive outlook despite a 25% decrease in estimated value. Analysts project an average target price of $33.00, suggesting a potential upside of 56.92% from the current price of $21.03. The consensus recommendation remains at "Outperform," reflecting confidence in CEVA's future performance.
A recent report revealed that over 1.2 million people were affected by banking outages on payday, with major UK banks experiencing a total of 803 hours of tech failures in the past two years. Barclays may face £12.5 million in compensation for a January outage, highlighting the urgent need for IT modernization to maintain customer trust. Experts warn that failure to address these issues could lead to reputational damage and loss of customers, particularly during critical financial periods.
Financial Scams and Security
SubCategory
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
credit suisse faces fallout from us black money scandal and legal failures
United States Dollar
Swiss Franc
Schellenberg Wittmer AG
PKB PRIVATBANK SA
Swiss Life, Agence générale Canton de Fribourg, Daniel Piller, Agent Général
CHE
COL
VEN
USA
Urs Rohner
Rainer Gut
Romeo Cerutti
Bidzina Ivanishvili
Dan Horsky
Show more
07:58 09.05.2025
Bruker price target lowered to 45 by UBS while maintaining neutral rating
21:33 08.05.2025
ubs lowers ehealth price target to seven dollars amid market reassessment
21:32 08.05.2025
ubs lowers veracyte price target but maintains buy rating
20:36 08.05.2025
ubs lowers price target for angi maintains neutral rating
20:35 08.05.2025
ubs lowers price target for amplitude to eleven dollars while maintaining neutral rating
20:35 08.05.2025
Barclays Lowers B&G Foods Price Target While Maintaining Equal-Weight Rating
20:01 08.05.2025
barclays maintains equal weight rating and lowers price target for dayforce
19:32 08.05.2025
barclays lowers price target for ceva while maintaining overweight rating
19:05 08.05.2025
banking sector faces scrutiny over widespread IT outages affecting millions
15:28 08.05.2025
Trending
Subcategory
Corporate News
Startups & Entrepreneurship
Venture Capital Investments
Industry Trends
Fintech Startups
Cryptocurrency Trends
Emerging Startups
Funding Rounds & Investments
AI Innovations
Crypto Policies and Governance
Retail and Consumer Goods
Crypto Adoption and Integration
IPOs & SPACs
Economic Indicators
Stock Market Updates
AI Applications
Finance Mergers & Acquisitions
Government Economic Policies
Product Launches
Inflation and Monetary Impact
Countries:
Companies:
Nvidia Corporation
Microsoft Corporation Corp.
Amazon.com Inc.
Alphabet Inc.
Micelio Technology Fund 1
PayPal Holdings Inc.
Uber Technologies Inc.
Indifi Technologies Ltd.
The Goldman Sachs Group, Inc.
Axis Capital Ltd.
UBS Group AG
Reddit Inc.
Google LLC
Anduril Industries Inc.
Maruishi Pharmaceutical Co. Ltd.
Qatar Islamic Bank ش.م.ع
Walmart Inc.
Trump Media & Technology Group Corp.
Contemporary Amperex Technology Co. Ltd.
Huawei Technologies CO. Ltd.
Currencies:
People: